Black Hawk Acquisition Corporation Class A Company Profile
NASDAQ: BKHAHealth CareBiotechnology: Biological Products (No Diagnostic Substances)USD
Market open · Delayed 15 min · as of Oct 9, 3:47 PM ET
Black Hawk Acquisition at a glance
Black Hawk Acquisition Corporation Class A (NASDAQ: BKHA) is a Biotechnology: Biological Products (No Diagnostic Substances) company in the Health Care sector headquartered in Danville, CA. Black Hawk Acquisition is led by Mr. Kent Louis Kaufman. The company's shares have traded publicly since 2024.
At a market capitalization of $51.2 million, it is considered a small-cap company. Its SEC Central Index Key (CIK) is 0002000775, which identifies the company's filings on EDGAR.
Summary generated from market data by MetaCap's automated system. Methodology
What does Black Hawk Acquisition do?
Black Hawk Acquisition Corporation is a blank check company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2023 and is based in Danville, California.
Business description based on the company's public filings.
Company information
- Legal name
- Black Hawk Acquisition Corporation Class A
- Ticker
- NASDAQ: BKHA
- Sector
- Health Care
- Industry
- Biotechnology: Biological Products (No Diagnostic Substances)
- CEO
- Mr. Kent Louis Kaufman
- Headquarters
- 125 Blackhawk Plaza Circle, Danville, CA, United States
- Phone
- 925 217 4482
- Website
- bhspac.com
- IPO year
- 2024
- Market cap
- $51.21M
- SEC CIK
- 0002000775
Companies similar to Black Hawk Acquisition
| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| INMBINmune Bio Inc. | 1.89 | +3.01% | $52.32M | vs BKHA |
| CRBUCaribou Biosciences Inc. | 0.4633 | -3.72% | $49.67M | vs BKHA |
| EXOZeXoZymes Inc. | 5.25 | -1.50% | $48.85M | vs BKHA |
| IMAImageneBio Inc. | 4.25 | -0.24% | $48.34M | vs BKHA |
| LONALeonaBio Inc. | 5.78 | +0.52% | $54.46M | vs BKHA |
| ELOXEloxx Pharmaceuticals Inc. | 13.51 | -11.03% | $54.51M | vs BKHA |
| INKTMiNK Therapeutics Inc. | 10.82 | -1.64% | $55.21M | vs BKHA |
| TVGNTevogen Inc. | 7.15 | +1.27% | $46.56M | vs BKHA |